Supriya Lifescience IPO Date, Price, GMP, Review, Allotment, Subscription, Analysis & Documents
- About Supriya Lifescience
- Important Details – Supriya Lifescience
- Objects of the Issue
- Supriya Lifescience Limited Financials:
- Supriya IPO Details
- Supriya IPO DRHP & RHP
- Supriya IPO Lot Size
- Supriya Lifescience IPO Lead Managers
- Supriya Lifescience IPO Registrar
- Supriya Lifescience IPO Allotment Date, Listing Date and other Important Dates
- Company Peers – Comparison of Accounting Ratios
- Company Registered and Corporate Office
- Company Promoters
- Supriya Lifescience IPO – FAQS
About Supriya Lifescience
Supriya Lifescience is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of October 31, 2021, Supriya Lifescience has niche product offerings of 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-50% and 60-65%, respectively, of the API exports from India,
between Fiscal 2017 and 2021.
Supriya Lifescience is one of the largest exporters of Salbutamol Sulphate in India contributing to 31% of the API exports from India in FY 2021 in volume terms. The pharmaceutical business is organized into domestic and export sales, according to the geographies in which the company operate.
The customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc and AT Planejamento E Desenbolvimento De Negocios Ltda, with whom the company has business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom Supriya Lifescience has business relationship for over four years.
Important Details – Supriya Lifescience
| Date | Details |
|---|---|
| March 26, 2008 | The company was incorporated as ‘Supriya Lifescience Limited’ |
Objects of the Issue
- Funding capital expenditure requirements of the Company;
- Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the Company and
- General corporate purposes
Supriya Lifescience Limited Financials:
Summary of financial Information (Restated Consolidated Statement)
| Particulars | For the year ended (₹ in millions) | ||
| 31-Mar-21 | 31-Mar-20 | 31-Mar-19 | |
| Total Assets | 4,458.24 | 3,364.30 | 2,530.52 |
| Total income | 3,962.21 | 3,227.13 | 2,858.62 |
| Total Expenses | 2,180.70 | 2,132.62 | 2,131.01 |
| Profit After Tax | 1,238.28 | 734.03 | 394.24 |
Supriya IPO Details
| Description | Supriya IPO Details |
|---|---|
| Public Issue | Initial Public Issue of upto [.] equity shares of ₹ 2 (aggregating up to ₹ 7,000 million) comprising a fresh issue of upto [.] equity shares of ₹ 2 (aggregating up to ₹ 2,000 million) and an offer of sale upto [.] equity shares of ₹ 2 (aggregating up to ₹ 5,000 million) |
| Issue Open Date | 16-Dec-21 |
| Issue Close Date | 20-Dec-21 |
| Issue Type | Book Building |
| IPO Price Band | ₹ 265 – ₹ 274 |
| Face Value | ₹ 2 |
| Market Lot | 54 Equity Shares and in multiples thereof |
| Minimum Order Quantity | 54 Equity Shares |
| Maximum Subscription Amount for Retail Investor | Rs. 2,00,000 |
| Listing | NSE, BSE |
| NSE Symbol | SUPRIYA |
| IPO Market Timings | 10.00 a.m. to 5.00 p.m. |
Supriya IPO DRHP & RHP
Supriya Lifescience IPO DRHP
Supriya Lifescience IPO RHP
Supriya IPO Lot Size
| Application | Lots | No of Shares | Amount (Rs) |
| Minimum | 1 | 54 | ₹ 14,796 |
| Maximum | 13 | 702 | ₹ 1,92,348 |
Supriya Lifescience IPO Lead Managers
- ICICI Securities Limited
- Axis Capital Limited
Supriya Lifescience IPO Registrar
Supriya Lifescience IPO Allotment Date, Listing Date and other Important Dates
| Details | Date |
|---|---|
| Bid / Offer Opens on | 16-Dec-21 |
| Bid / Offer Closes on | 20-Dec-21 |
| Finalisation of Basis of Allotment | 23-Dec-21 |
| Initiation of refunds | 24-Dec-21 |
| Credit of the Equity Shares | 27-Dec-21 |
| Listing Date | 28-Dec-21 |
Company Peers – Comparison of Accounting Ratios
| Name of Company | Face Value | EPS (Basic) (₹) | Total Income (₹ in million) | NAV, as on March 31, 2021 (₹ per share) |
| Supriya Lifescience Limited | 1 | 16.92 | 3,962.21 | 36.75 |
| Solara Active Pharma Sciences Limited | 10 | 69 | 16,457 | 443.3 |
| Neuland Laboratories Limited | 10 | 62.85 | 9,530 | 613 |
| Aarti Drugs Limited | 10 | 30.09 | 21,593 | 98 |
| Wanbury Limited | 10 | (5.04) | 3,949 | (62.5) |
| Divis Laboratories Limited | 2 | 74.75 | 70,320 | 350.10 |
Company Registered and Corporate Office
207/208, Udyog Bhavan,
Sonawala Road, Goregaon – East,
Mumbai – 400063,
Maharashtra, India
Website: www.supriyalifescience.com
Company Promoters
- Satish Waman Wagh
Supriya Lifescience IPO – FAQS
What is the Supriya Lifescience IPO Price?
The Supriya Lifescience IPO price band is ₹ 265 – ₹ 274 per share
When Supriya Lifescience IPO will open?
The Supriya Lifescience IPO opens on Dec 16, 2021 and closes on Dec 20, 2021
What is the lot size of Supriya Lifescience IPO?
The Supriya Lifescience IPO lot size is 54 Equity Shares and the minimum order quantity is 54 Equity Shares
Who is the Registrar for Supriya Lifescience IPO?
The Registrar for Supriya Lifescience IPO is Link Intime India Private Limited
How to apply in Supriya Lifescience IPO through UPI?
Check the step by step process here – Click here
How to apply in Supriya Lifescience IPO through Zerodha?
Check the step by step process here – Click here
Follow us on Telegram for all the latest updates
